Anticorps Recombinant de lapin anti-VEGFR1/Flt-1

VEGFR1/Flt-1 Recombinant Antibody for WB, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

rat, souris

Applications

WB, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

242311A4

N° de cat : 85761-4-PBS

Synonymes

Flt1, FLT-1, VEGFR-1, VGFR1



Informations sur le produit

85761-4-PBS cible VEGFR1/Flt-1 dans les applications de WB, Indirect ELISA et montre une réactivité avec des échantillons rat, souris

Réactivité rat, souris
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène VEGFR1/Flt-1 Protéine recombinante Eg1167
Nom complet fms-related tyrosine kinase 1
Poids moléculaire observé 150-210 kDa
Symbole du gène Flt1
Identification du gène (NCBI) 54251
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Vascular endothelial growth factor receptor-1 (VEGFR-1, FLT-1) is a receptor tyrosine kinase belonging to the VEGFR family. VEGF is a key regulator of physiological angiogenesis and has also been implicated in pathological angiogenesis associated with tumors, intraocular neovascular disorders, and other conditions. The biological effects of VEGF are mediated by VEGFR-1 and VEGFR-2. Both the two receptors have seven immunoglobulin-like repeats in the extracellular domain, a single transmembrane region and a tyrosine kinase domain. VEGFR-1 binds VEGFA, PIGF, and VEGFB, and plays an essential role in the development of embryonic vasculature, the regulation of angiogenesis, cell survival, cell migration, macrophage function, chemotaxis, and cancer cell invasion. Two isoforms of VEGFR-1 exist, a full-length transmembrane form and a short soluble form (sVEGFR-1) consisting of only the extracellular ligand-binding domain. (PMID: 12778165; 17109193; 8806634)

{{ptg:RelatedPrimaryAntibodies}}